Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selexipag. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214169B reveals a mild, high-yield route for pyrazine intermediates. Discover cost-effective manufacturing strategies for pulmonary hypertension drugs.
Novel patent CN119143682A offers safer Selapage intermediate synthesis. Eliminating POCl3 reduces cost and improves supply chain reliability for pharmaceutical manufacturers.